Selected research
Market Analysis & Forecast
Global Veterinary Health Products Market Analysis and Forecast 2026-2032
Market perspective
The global Veterinary Health Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Veterinary Health Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Veterinary Health Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Veterinary Health Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Veterinary Health Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Veterinary Health Products include Zoetis, Novartis Animal Health, Bayer, BASF, Virbac, Heska, Elanco, DSM and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Veterinary Health Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Veterinary Health Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Health Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Health Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Health Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Health Products revenue, projected growth trends, production technology, application and end-user industry.
Veterinary Health Products Segment by Company
Zoetis
Novartis Animal Health
Bayer
BASF
Virbac
Heska
Elanco
DSM
Boehringer Ingelheim
Alpharma Animal Health
Adisseo France
Veterinary Health Products Segment by Type
Vaccines
Performance Enhancers
Feed Additives
Animal Pharmaceuticals
Others
Veterinary Health Products Segment by Application
Poultry
Livestock
Pet
Veterinary Health Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Health Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Health Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Health Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Veterinary Health Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Veterinary Health Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Health Products revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccines
- Performance Enhancers
- Feed Additives
- Animal Pharmaceuticals
- Others
Applications
- Poultry
- Livestock
- Pet
Companies covered
- Zoetis
- Novartis Animal Health
- Bayer
- BASF
- Virbac
- Heska
- Elanco
- DSM
- Boehringer Ingelheim
- Alpharma Animal Health
- Adisseo France
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Veterinary Health Products Market by Type
- 1.2.1 Global Veterinary Health Products Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Vaccines
- 1.2.3 Performance Enhancers
- 1.2.4 Feed Additives
- 1.2.5 Animal Pharmaceuticals
- 1.2.6 Others
- 1.3 Veterinary Health Products Market by Application
- 1.3.1 Global Veterinary Health Products Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Poultry
- 1.3.3 Livestock
- 1.3.4 Pet
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Health Products Market Dynamics
- 2.1 Veterinary Health Products Industry Trends
- 2.2 Veterinary Health Products Industry Drivers
- 2.3 Veterinary Health Products Industry Opportunities and Challenges
- 2.4 Veterinary Health Products Industry Restraints
3 Global Growth Perspective
- 3.1 Global Veterinary Health Products Market Perspective (2021-2032)
- 3.2 Global Veterinary Health Products Growth Trends by Region
- 3.2.1 Global Veterinary Health Products Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Veterinary Health Products Market Size by Region (2021-2026)
- 3.2.3 Global Veterinary Health Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Veterinary Health Products Revenue by Players
- 4.1.1 Global Veterinary Health Products Revenue by Players (2021-2026)
- 4.1.2 Global Veterinary Health Products Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Veterinary Health Products Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Veterinary Health Products Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Veterinary Health Products Key Players Headquarters & Area Served
- 4.4 Global Veterinary Health Products Players, Product Type & Application
- 4.5 Global Veterinary Health Products Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Veterinary Health Products Market CR5 and HHI
- 4.6.3 2025 Veterinary Health Products Tier 1, Tier 2, and Tier 3
5 Veterinary Health Products Market Size by Type
- 5.1 Global Veterinary Health Products Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary Health Products Revenue by Type (2021-2032)
- 5.3 Global Veterinary Health Products Revenue Market Share by Type (2021-2032)
6 Veterinary Health Products Market Size by Application
- 6.1 Global Veterinary Health Products Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Veterinary Health Products Revenue by Application (2021-2032)
- 6.3 Global Veterinary Health Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.1.4 Zoetis Veterinary Health Products Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Novartis Animal Health
- 7.2.1 Novartis Animal Health Company Information
- 7.2.2 Novartis Animal Health Business Overview
- 7.2.3 Novartis Animal Health Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.2.4 Novartis Animal Health Veterinary Health Products Product Portfolio
- 7.2.5 Novartis Animal Health Recent Developments
- 7.3 Bayer
- 7.3.1 Bayer Company Information
- 7.3.2 Bayer Business Overview
- 7.3.3 Bayer Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.3.4 Bayer Veterinary Health Products Product Portfolio
- 7.3.5 Bayer Recent Developments
- 7.4 BASF
- 7.4.1 BASF Company Information
- 7.4.2 BASF Business Overview
- 7.4.3 BASF Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.4.4 BASF Veterinary Health Products Product Portfolio
- 7.4.5 BASF Recent Developments
- 7.5 Virbac
- 7.5.1 Virbac Company Information
- 7.5.2 Virbac Business Overview
- 7.5.3 Virbac Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.5.4 Virbac Veterinary Health Products Product Portfolio
- 7.5.5 Virbac Recent Developments
- 7.6 Heska
- 7.6.1 Heska Company Information
- 7.6.2 Heska Business Overview
- 7.6.3 Heska Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.6.4 Heska Veterinary Health Products Product Portfolio
- 7.6.5 Heska Recent Developments
- 7.7 Elanco
- 7.7.1 Elanco Company Information
- 7.7.2 Elanco Business Overview
- 7.7.3 Elanco Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.7.4 Elanco Veterinary Health Products Product Portfolio
- 7.7.5 Elanco Recent Developments
- 7.8 DSM
- 7.8.1 DSM Company Information
- 7.8.2 DSM Business Overview
- 7.8.3 DSM Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.8.4 DSM Veterinary Health Products Product Portfolio
- 7.8.5 DSM Recent Developments
- 7.9 Boehringer Ingelheim
- 7.9.1 Boehringer Ingelheim Company Information
- 7.9.2 Boehringer Ingelheim Business Overview
- 7.9.3 Boehringer Ingelheim Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.9.4 Boehringer Ingelheim Veterinary Health Products Product Portfolio
- 7.9.5 Boehringer Ingelheim Recent Developments
- 7.10 Alpharma Animal Health
- 7.10.1 Alpharma Animal Health Company Information
- 7.10.2 Alpharma Animal Health Business Overview
- 7.10.3 Alpharma Animal Health Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.10.4 Alpharma Animal Health Veterinary Health Products Product Portfolio
- 7.10.5 Alpharma Animal Health Recent Developments
- 7.11 Adisseo France
- 7.11.1 Adisseo France Company Information
- 7.11.2 Adisseo France Business Overview
- 7.11.3 Adisseo France Veterinary Health Products Revenue and Gross Margin (2021-2026)
- 7.11.4 Adisseo France Veterinary Health Products Product Portfolio
- 7.11.5 Adisseo France Recent Developments
8 North America
- 8.1 North America Veterinary Health Products Revenue (2021-2032)
- 8.2 North America Veterinary Health Products Revenue by Type (2021-2032)
- 8.2.1 North America Veterinary Health Products Revenue by Type (2021-2026)
- 8.2.2 North America Veterinary Health Products Revenue by Type (2027-2032)
- 8.3 North America Veterinary Health Products Revenue Share by Type (2021-2032)
- 8.4 North America Veterinary Health Products Revenue by Application (2021-2032)
- 8.4.1 North America Veterinary Health Products Revenue by Application (2021-2026)
- 8.4.2 North America Veterinary Health Products Revenue by Application (2027-2032)
- 8.5 North America Veterinary Health Products Revenue Share by Application (2021-2032)
- 8.6 North America Veterinary Health Products Revenue by Country
- 8.6.1 North America Veterinary Health Products Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Veterinary Health Products Revenue by Country (2021-2026)
- 8.6.3 North America Veterinary Health Products Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Veterinary Health Products Revenue (2021-2032)
- 9.2 Europe Veterinary Health Products Revenue by Type (2021-2032)
- 9.2.1 Europe Veterinary Health Products Revenue by Type (2021-2026)
- 9.2.2 Europe Veterinary Health Products Revenue by Type (2027-2032)
- 9.3 Europe Veterinary Health Products Revenue Share by Type (2021-2032)
- 9.4 Europe Veterinary Health Products Revenue by Application (2021-2032)
- 9.4.1 Europe Veterinary Health Products Revenue by Application (2021-2026)
- 9.4.2 Europe Veterinary Health Products Revenue by Application (2027-2032)
- 9.5 Europe Veterinary Health Products Revenue Share by Application (2021-2032)
- 9.6 Europe Veterinary Health Products Revenue by Country
- 9.6.1 Europe Veterinary Health Products Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Veterinary Health Products Revenue by Country (2021-2026)
- 9.6.3 Europe Veterinary Health Products Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Veterinary Health Products Revenue (2021-2032)
- 10.2 China Veterinary Health Products Revenue by Type (2021-2032)
- 10.2.1 China Veterinary Health Products Revenue by Type (2021-2026)
- 10.2.2 China Veterinary Health Products Revenue by Type (2027-2032)
- 10.3 China Veterinary Health Products Revenue Share by Type (2021-2032)
- 10.4 China Veterinary Health Products Revenue by Application (2021-2032)
- 10.4.1 China Veterinary Health Products Revenue by Application (2021-2026)
- 10.4.2 China Veterinary Health Products Revenue by Application (2027-2032)
- 10.5 China Veterinary Health Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Veterinary Health Products Revenue (2021-2032)
- 11.2 Asia Veterinary Health Products Revenue by Type (2021-2032)
- 11.2.1 Asia Veterinary Health Products Revenue by Type (2021-2026)
- 11.2.2 Asia Veterinary Health Products Revenue by Type (2027-2032)
- 11.3 Asia Veterinary Health Products Revenue Share by Type (2021-2032)
- 11.4 Asia Veterinary Health Products Revenue by Application (2021-2032)
- 11.4.1 Asia Veterinary Health Products Revenue by Application (2021-2026)
- 11.4.2 Asia Veterinary Health Products Revenue by Application (2027-2032)
- 11.5 Asia Veterinary Health Products Revenue Share by Application (2021-2032)
- 11.6 Asia Veterinary Health Products Revenue by Country
- 11.6.1 Asia Veterinary Health Products Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Veterinary Health Products Revenue by Country (2021-2026)
- 11.6.3 Asia Veterinary Health Products Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Veterinary Health Products Revenue (2021-2032)
- 12.2 SAMEA Veterinary Health Products Revenue by Type (2021-2032)
- 12.2.1 SAMEA Veterinary Health Products Revenue by Type (2021-2026)
- 12.2.2 SAMEA Veterinary Health Products Revenue by Type (2027-2032)
- 12.3 SAMEA Veterinary Health Products Revenue Share by Type (2021-2032)
- 12.4 SAMEA Veterinary Health Products Revenue by Application (2021-2032)
- 12.4.1 SAMEA Veterinary Health Products Revenue by Application (2021-2026)
- 12.4.2 SAMEA Veterinary Health Products Revenue by Application (2027-2032)
- 12.5 SAMEA Veterinary Health Products Revenue Share by Application (2021-2032)
- 12.6 SAMEA Veterinary Health Products Revenue by Country
- 12.6.1 SAMEA Veterinary Health Products Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Veterinary Health Products Revenue by Country (2021-2026)
- 12.6.3 SAMEA Veterinary Health Products Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst